Evidence map›Paper›PMID 37488096›Full record

ArticleNature communications2023

ORC1 binds to cis-transcribed RNAs for efficient activation of replication origins.

Aina Maria Mas, Enrique Goñi, Igor Ruiz de Los Mozos, Aida Arcas, Luisa Statello, Jovanna González, Lorea Blázquez, Wei Ting Chelsea Lee, Dipika Gupta, Álvaro Sejas and 8 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
4.9field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 9 institutions in 5 countries.

Aina Maria MasCenter for Applied Medical Research, University of Navarra, Pio XII 55 Ave, 31008, Pamplona, Spain.ORCID 0000-0002-1167-5025
Enrique Goñi *Center for Applied Medical Research, University of Navarra, Pio XII 55 Ave, 31008, Pamplona, Spain.ORCID 0000-0003-1792-4018
Igor Ruiz de Los Mozos *Center for Applied Medical Research, University of Navarra, Pio XII 55 Ave, 31008, Pamplona, Spain.ORCID 0000-0003-4097-6422
Aida Arcas *Center for Applied Medical Research, University of Navarra, Pio XII 55 Ave, 31008, Pamplona, Spain.ORCID 0000-0001-9182-0810
Luisa StatelloCenter for Applied Medical Research, University of Navarra, Pio XII 55 Ave, 31008, Pamplona, Spain.ORCID 0000-0001-8261-4214
Jovanna GonzálezCenter for Applied Medical Research, University of Navarra, Pio XII 55 Ave, 31008, Pamplona, Spain.
Lorea BlázquezRNA Networks Lab, The Francis Crick Institute, NW11BF, London, UK.
Wei Ting Chelsea LeeDepartment of Biochemistry and Molecular Pharmacology, Perlmutter Cancer Center, New York University School of Medicine, New York, NY, 10016, USA.
Dipika GuptaDepartment of Biochemistry and Molecular Pharmacology, Perlmutter Cancer Center, New York University School of Medicine, New York, NY, 10016, USA.ORCID 0000-0002-6512-5256
Álvaro SejasCenter for Applied Medical Research, University of Navarra, Pio XII 55 Ave, 31008, Pamplona, Spain.
Shoko HoshinaDepartment of Chemical and Biological Sciences, Japan Women's University, Tokyo, 112-8681, Japan.
Alexandros ArmaosCenter for Human Technologies, Istituto Italiano di Tecnologia, Genova, Italy.
Gian Gaetano TartagliaCenter for Human Technologies, Istituto Italiano di Tecnologia, Genova, Italy.
Shou WagaDepartment of Chemical and Biological Sciences, Japan Women's University, Tokyo, 112-8681, Japan.ORCID 0000-0003-4986-8735
Jernej UleRNA Networks Lab, The Francis Crick Institute, NW11BF, London, UK.ORCID 0000-0002-2452-4277
Eli RothenbergDepartment of Biochemistry and Molecular Pharmacology, Perlmutter Cancer Center, New York University School of Medicine, New York, NY, 10016, USA.
María GómezCentro de Biología Molecular Severo Ochoa (CBMSO), Consejo Superior de Investigaciones Científicas/Universidad Autónoma de Madrid (CSIC/UAM), Nicolás Cabrera 1, 28049, Madrid, Spain.ORCID 0000-0002-3266-7999
Maite HuarteCenter for Applied Medical Research, University of Navarra, Pio XII 55 Ave, 31008, Pamplona, Spain. maitehuarte@unav.es.ORCID 0000-0003-3753-6493
Clinica Universidad de Navarra · ESNew York University · USJapan Women's University · JPConsejo Superior de Investigaciones Científicas · ESIkerbasque · ESInstitució Catalana de Recerca i Estudis Avançats · ESItalian Institute of Technology · ITNavarre Institute of Health Research · ESThe Francis Crick Institute · GB

Funding

Structural determinants of Pol theta functionP01CA247773 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DALE A RAMSDEN · 2020 to 2026
$15.2M
Mechanisms of Human DNA Double-Strand Break Repair via Quantitative Single-Molecule Imaging - Equipment SupplementR35GM134947 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Eli Rothenberg · 2020 to 2026
$3.4M
Mechanism and Fidelity of RAG mediated DNA recombinationR01AI153040 · NIAID · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI ROTHENBERG, ELI · 2020 to 2024
$2.7M
NCI NIH HHS P01 CA247773NIAID NIH HHS R01 AI153040NIGMS NIH HHS R35 GM134947
6 · The paper itself

Abstract

Cells must coordinate the activation of thousands of replication origins dispersed throughout their genome. Active transcription is known to favor the formation of mammalian origins, although the role that RNA plays in this process remains unclear. We show that the ORC1 subunit of the human Origin Recognition Complex interacts with RNAs transcribed from genes with origins in their transcription start sites (TSSs), displaying a positive correlation between RNA binding and origin activity. RNA depletion, or the use of ORC1 RNA-binding mutant, result in inefficient activation of proximal origins, linked to impaired ORC1 chromatin release. ORC1 RNA binding activity resides in its intrinsically disordered region, involved in intra- and inter-molecular interactions, regulation by phosphorylation, and phase-separation. We show that RNA binding favors ORC1 chromatin release, by regulating its phosphorylation and subsequent degradation. Our results unveil a non-coding function of RNA as a dynamic component of the chromatin, orchestrating the activation of replication origins.

Indexed as

ChromatinReplication OriginAnimalsHumansMammalsOrigin Recognition ComplexPhosphorylationRNAChromatinORC1 protein, humanOrigin Recognition ComplexRNA

Identifiers

PMID37488096
PMCPMC10366126
OpenAlexW4385230584

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.